Literature DB >> 17596701

Tyrosine 687 phosphorylated Alzheimer's amyloid precursor protein is retained intracellularly and exhibits a decreased turnover rate.

Sandra Rebelo1, Sandra Isabel Vieira, Hermann Esselmann, Jens Wiltfang, Edgar F da Cruz e Silva, Odete A B da Cruz e Silva.   

Abstract

Tyrosine 687 (Y687) of the Alzheimer's amyloid precursor protein (APP) was shown to be phosphorylated in the brains of Alzheimer's disease patients. This residue lies within a typical endocytosis consensus motif commonly found in molecules with receptor functions, strongly suggesting a potential role for APP in signal transduction. Consequently, the work here described addressed how phosphorylation of Y687 may be affecting APP in terms of its proteolytic cleavage and subcellular distribution. Our data show that the APP mutant mimicking constitutive dephosphorylation of Y687 had a faster turnover rate, both in terms of maturation and metabolism, when compared to Wt-APP-GFP and even more so when compared to the mutant mimicking constitutive phosphorylation. Thus, the mutant mimicking constitutively phosphorylated Y687 had a much higher t(1/2) and was significantly retained both in the ER and TGN. Additionally, this mutant was not incorporated into visible vesicular structures, with a concomitant dramatic decrease in Abeta production. Our findings point to the direct phosphorylation of APP on Y687 as an important regulatory mechanism in terms of determining the subcellular localization of APP and modulating its processing via different proteolytic pathways. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596701     DOI: 10.1159/000101831

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  14 in total

1.  Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling.

Authors:  Ci-Di Chen; Ella Zeldich; Christina Khodr; Kaddy Camara; Tze Yu Tung; Emma C Lauder; Patrick Mullen; Taryn J Polanco; Yen-Yu Liu; Dean Zeldich; Weiming Xia; William E Van Nostrand; Lauren E Brown; John A Porco; Carmela R Abraham
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 2.  Golgi defects enhance APP amyloidogenic processing in Alzheimer's disease.

Authors:  Gunjan Joshi; Yanzhuang Wang
Journal:  Bioessays       Date:  2014-12-28       Impact factor: 4.345

Review 3.  Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.

Authors:  Filipa I Baptista; Ana G Henriques; Artur M S Silva; Jens Wiltfang; Odete A B da Cruz e Silva
Journal:  ACS Chem Neurosci       Date:  2014-01-03       Impact factor: 4.418

4.  Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.

Authors:  Sandra I Vieira; Sandra Rebelo; Hermann Esselmann; Jens Wiltfang; James Lah; Rachel Lane; Scott A Small; Sam Gandy; Edgar F da Cruz E Silva; Odete Ab da Cruz E Silva
Journal:  Mol Neurodegener       Date:  2010-10-11       Impact factor: 14.195

5.  S655 phosphorylation enhances APP secretory traffic.

Authors:  Sandra Isabel Vieira; Sandra Rebelo; Sara Catarina Domingues; Edgar F da Cruz e Silva; Odete A B da Cruz e Silva
Journal:  Mol Cell Biochem       Date:  2009-04-21       Impact factor: 3.396

6.  TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer's disease pathologies.

Authors:  Yiyuan Xia; Zhi-Hao Wang; Pai Liu; Laura Edgington-Mitchell; Xia Liu; Xiao-Chuan Wang; Keqiang Ye
Journal:  Mol Psychiatry       Date:  2020-08-11       Impact factor: 15.992

Review 7.  Modulation of dendritic spines by protein phosphatase-1.

Authors:  Jimcy Platholi; Hugh C Hemmings
Journal:  Adv Pharmacol       Date:  2020-11-19

8.  Mitosis-specific phosphorylation of amyloid precursor protein at threonine 668 leads to its altered processing and association with centrosomes.

Authors:  Monique Judge; Lisa Hornbeck; Huntington Potter; Jaya Padmanabhan
Journal:  Mol Neurodegener       Date:  2011-11-23       Impact factor: 14.195

9.  Identification of a novel human LAP1 isoform that is regulated by protein phosphorylation.

Authors:  Mariana Santos; Sara C Domingues; Patrícia Costa; Thorsten Muller; Sara Galozzi; Katrin Marcus; Edgar F da Cruz e Silva; Odete A da Cruz e Silva; Sandra Rebelo
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

10.  An Aberrant Phosphorylation of Amyloid Precursor Protein Tyrosine Regulates Its Trafficking and the Binding to the Clathrin Endocytic Complex in Neural Stem Cells of Alzheimer's Disease Patients.

Authors:  Ebbe T Poulsen; Filomena Iannuzzi; Helle F Rasmussen; Thorsten J Maier; Jan J Enghild; Arne L Jørgensen; Carmela Matrone
Journal:  Front Mol Neurosci       Date:  2017-03-15       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.